CIP
TRIB

Chartwell Investment Partners’s Trinity Biotech TRIB Stock Holding History

Chartwell Investment Partners’s Portfolio TRIB Stock Details TRIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-111,354
Closed -$10.2M – 376
2014
Q3 		$10.2M Sell
111,354
-23,135
-17% -$2.51M 0.23% 177
2014
Q2 		$15.5M Buy
134,489
+54,444
+68% +$6.45M 0.32% 130
2014
Q1 		$9.7M Sell
80,045
-369
-0.5% -$48.4K 0.2% 184
2013
Q4 		$10.1M Sell
80,414
-20,227
-20% -$2.43M 0.21% 185
2013
Q3 		$10.9M Sell
100,641
-5,480
-5% -$534K 0.25% 172
2013
Q2 		$8.94M Buy
+106,121
New +$8.8M 0.23% 179

Other funds holding TRIB

HA
Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return
CCMLC
Cardinal Capital Management LLC (Connecticut) Greenwich, Connecticut $365M AUM 18.32% 1-Year Est. Return
LSC
Lyon Street Capital Sausalito, California $67M AUM
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
TAM
THB Asset Management Norwalk, Connecticut $440M AUM 59.59% 1-Year Est. Return
AAM
ACK Asset Management Greenwich, Connecticut $801M AUM 60.42% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
CAM
Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
WA
Whitebox Advisors Minneapolis, Minnesota $8.12B AUM 15.85% 1-Year Est. Return

Chartwell Investment Partners's TRIB Position: Q4 2014 in Review

Chartwell Investment Partners sold out of Trinity Biotech (TRIB) in Q4 2014, closing a stake of 111,354 shares — an estimated $10.2M sold.

Chartwell Investment Partners first reported a position in TRIB in Q2 2013 and held it in 6 quarters. The position peaked at $15.5M in Q2 2014. 92 funds tracked by Wall St. Rank hold TRIB as of Q4 2014.

  • Chartwell Investment Partners reported no remaining Trinity Biotech position as of Q4 2014 after selling out during the quarter.
  • Chartwell Investment Partners sold 111,354 Trinity Biotech shares in Q4 2014, an estimated $10.2M.
  • Chartwell Investment Partners first reported a position in Trinity Biotech in Q2 2013 and held it in 6 quarters.
  • Chartwell Investment Partners's Trinity Biotech position peaked at $15.5M in Q2 2014.
  • 92 funds tracked by Wall St. Rank held Trinity Biotech as of Q4 2014.

Based on Chartwell Investment Partners's 13F filing for Q4 2014, filed 9 Feb 2015.